文献速递眼底病与葡萄膜炎

内皮TRPV1通过NF-κB信号驱动湿性年龄相关性黄斑变性脉络膜新生血管

Endothelial TRPV1 Drives Choroidal Neovascularization in Wet Age-Related Macular Degeneration via NF-κB Signaling.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究探讨内皮细胞瞬时受体电位香草酸亚型1(TRPV1)激活对新生血管和内皮-小胶质细胞交互的影响,以阐明湿性年龄相关性黄斑变性(wAMD)中脉络膜新生血管(CNV)的机制。生物信息学分析显示wAMD患者视网膜色素上皮-脉络膜组织中TRPV1上调,激光诱导CNV小鼠中TRPV1也上调;TRPV1激活加重血管渗漏,抑制或敲除则相反。内皮TRPV1通过NF-κB促进炎症因子释放,诱导小胶质细胞促炎极化及血管生成因子分泌,亚油酸作为生理配体激活该通路促进血管生成。

要点

  • TRPV1在wAMD患者和激光诱导CNV小鼠中表达上调。
  • 内皮TRPV1激活通过NF-κB促进炎症因子释放和小胶质细胞促炎极化,加剧CNV。
  • 亚油酸作为TRPV1生理配体激活内皮TRPV1/NF-κB通路促进血管生成。

核心结论

  • 内皮TRPV1通过NF-κB介导内皮功能障碍和小胶质细胞激活,从而促进CNV,亚油酸是关键激活物。
  • TRPV1可作为治疗wAMD的潜在治疗靶点。

研究设计与样本

  • 对wAMD患者视网膜色素上皮-脉络膜组织转录组进行生物信息学分析。
  • 使用激光诱导CNV小鼠和TRPV1敲除(TRPV1-/-)小鼠,通过眼底荧光素血管造影、光学相干断层扫描、苏木精-伊红染色和异凝集素B4染色评估血管渗漏。
  • 通过免疫荧光、蛋白质印迹和定量实时聚合酶链反应分析CNV小鼠中TRPV1表达。
  • 通过药理干预、siRNA沉默和共培养实验检查血管生成和小胶质细胞激活。
  • 通过公共代谢组学数据集分析TRPV1的生理激动剂。

主要发现

  • TRPV1在wAMD患者和激光诱导CNV小鼠中上调。
  • TRPV1激活加重CNV小鼠血管渗漏,抑制或敲除则产生相反效果。
  • 在人脐静脉和视网膜微血管内皮细胞中,TRPV1激活促进管腔形成,对增殖或迁移无可测量影响。
  • TRPV1通过调节NF-κB通路促进内皮细胞释放炎症因子,进而诱导小胶质细胞促炎极化和血管生成因子分泌,进一步促进血管生成。
  • 亚油酸作为TRPV1生理配体激活内皮TRPV1/NF-κB通路促进血管生成。

临床怎么用

  • TRPV1可作为治疗wAMD的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the effects of endothelial cell transient receptor potential vanilloid 1 (TRPV1) activation on neovascularization and endothelial cell-microglial crosstalk, aiming to clarify the mechanisms underlying choroidal neovascularization (CNV) in wet age-related macular degeneration (wAMD). METHODS: We performed bioinformatics analysis on transcriptomes of retinal pigment epithelium-choroidal tissues from wAMD patients. Vascular leakage was assessed in laser-induced CNV and TRPV1 knockout (TRPV1-/-) mice using fundus fluorescein angiography, optical coherence tomography, hematoxylin and eosin staining, and isolectin B4 staining. TRPV1 expression in CNV mice was determined via immunofluorescence, western blotting, and quantitative real-time polymerase chain reaction analyses. Angiogenesis and microglial activation were examined via pharmacological intervention, siRNA silencing, and co-culture assays. Physiological TRPV1 agonists were analyzed by public metabolomics datasets. RESULTS: TRPV1 was upregulated in patients with wAMD and mice with laser-induced CNV. TRPV1 activation exacerbated vascular leakage in CNV mice, whereas inhibition or knockout had the opposite effects. In human umbilical vein and retinal microvascular endothelial cells, TRPV1 activation promoted tube formation, with no measurable effects on proliferation or migration. TRPV1 promoted the release of inflammatory factors from endothelial cells by regulating the nuclear factor kappa B (NF-κB) pathway, which in turn induced pro-inflammatory polarization of microglia and the secretion of angiogenic factors from microglia, further facilitating angiogenesis. Moreover, linoleic acid, a physiological ligand of TRPV1, activated the endothelial TRPV1/NF-κB pathway to promote angiogenesis. CONCLUSIONS: Endothelial TRPV1 mediated endothelial dysfunction and microglial activation via NF-κB, thereby promoting CNV, with linoleic acid serving as a key activator. TRPV1 can be considered a potential therapeutic target for treating wAMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sun N, Li J, Wang J, et al. Endothelial TRPV1 Drives Choroidal Neovascularization in Wet Age-Related Macular Degeneration via NF-κB Signaling. Invest Ophthalmol Vis Sci. 2026. PMID: 42047667. doi:10.1167/iovs.67.4.64

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。